Published in Nat Rev Clin Oncol on March 01, 2011
Systems cancer medicine: towards realization of predictive, preventive, personalized and participatory (P4) medicine. J Intern Med (2012) 2.13
Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med (2011) 1.78
Personalized genomic medicine and the rhetoric of empowerment. Hastings Cent Rep (2012) 1.64
Mass spectrometry strategies in metabolomics. J Biol Chem (2011) 1.60
Revolutionizing medicine in the 21st century through systems approaches. Biotechnol J (2012) 1.60
Ethical issues in health research with novel online sources. Am J Public Health (2012) 1.45
A population approach to precision medicine. Am J Prev Med (2012) 1.44
Adapting standards: ethical oversight of participant-led health research. PLoS Med (2013) 1.43
Knowledge Discovery and interactive Data Mining in Bioinformatics--State-of-the-Art, future challenges and research directions. BMC Bioinformatics (2014) 1.41
Identification of anticancer drugs for hepatocellular carcinoma through personalized genome-scale metabolic modeling. Mol Syst Biol (2014) 1.26
P5 medicine: a plus for a personalized approach to oncology. Nat Rev Clin Oncol (2011) 1.17
Bioinformatics for precision medicine in oncology: principles and application to the SHIVA clinical trial. Front Genet (2014) 1.17
Improving data and knowledge management to better integrate health care and research. J Intern Med (2013) 1.15
From P0 to P6 medicine, a model of highly participatory, narrative, interactive, and "augmented" medicine: some considerations on Salvatore Iaconesi's clinical story. Patient Prefer Adherence (2013) 1.15
Understanding drug uptake and binding within targeted disease micro-environments in patients: a new tool for translational medicine. Clin Transl Med (2012) 1.14
Multiplexed volumetric bar-chart chip for point-of-care diagnostics. Nat Commun (2012) 1.13
Outlier kinase expression by RNA sequencing as targets for precision therapy. Cancer Discov (2013) 1.13
SRM targeted proteomics in search for biomarkers of HCV-induced progression of fibrosis to cirrhosis in HALT-C patients. Proteomics (2012) 1.11
How can polygenic inheritance be used in population screening for common diseases? Genet Med (2013) 1.10
Participatory medicine: a driving force for revolutionizing healthcare. Genome Med (2013) 1.10
Cancer bioinformatics: a new approach to systems clinical medicine. BMC Bioinformatics (2012) 1.08
The MURDOCK Study: a long-term initiative for disease reclassification through advanced biomarker discovery and integration with electronic health records. Am J Transl Res (2012) 1.05
Collaborative biomedicine in the age of big data: the case of cancer. J Med Internet Res (2014) 1.04
Systems virology: host-directed approaches to viral pathogenesis and drug targeting. Nat Rev Microbiol (2013) 1.02
p-Medicine: From data sharing and integration via VPH models to personalized medicine. Ecancermedicalscience (2011) 0.99
Somatic variation and cancer: therapies lost in the mix. Hum Genet (2011) 0.99
Preclinical Mouse Cancer Models: A Maze of Opportunities and Challenges. Cell (2015) 0.99
The human proteome - a scientific opportunity for transforming diagnostics, therapeutics, and healthcare. Clin Proteomics (2012) 0.98
Synergy-COPD: a systems approach for understanding and managing chronic diseases. J Transl Med (2014) 0.94
Systems pharmacology meets predictive, preventive, personalized and participatory medicine. Pharmacogenomics (2013) 0.93
Seeking Genomic Knowledge: The Case for Clinical Restraint. Hastings Law J (2013) 0.89
Practicing pathology in the era of big data and personalized medicine. Appl Immunohistochem Mol Morphol (2014) 0.88
Big Data Analytics in Healthcare. Biomed Res Int (2015) 0.87
267 Spanish Exomes Reveal Population-Specific Differences in Disease-Related Genetic Variation. Mol Biol Evol (2016) 0.86
Personalized health care as a pathway for the adoption of genomic medicine. J Pers Med (2012) 0.85
The emerging agenda of stratified medicine in neurology. Nat Rev Neurol (2013) 0.85
Rethinking psychiatry with OMICS science in the age of personalized P5 medicine: ready for psychiatome? Philos Ethics Humanit Med (2013) 0.85
A surveillance tool to support quality assurance and research in personalized medicine. AMIA Annu Symp Proc (2011) 0.84
Profile of European adults interested in internet-based personalised nutrition: the Food4Me study. Eur J Nutr (2015) 0.84
Systems medicine: evolution of systems biology from bench to bedside. Wiley Interdiscip Rev Syst Biol Med (2015) 0.83
Comparative effectiveness research in cancer: what has been funded and what knowledge gaps remain? J Natl Cancer Inst (2013) 0.82
Patient-Centered Cancer Care Programs in Italy: Benchmarking Global Patient Education Initiatives. J Cancer Educ (2016) 0.80
Big data in medical science--a biostatistical view. Dtsch Arztebl Int (2015) 0.80
Ethical, legal and social implications of incorporating personalized medicine into healthcare. Per Med (2015) 0.80
The Reactive Species Interactome: Evolutionary Emergence, Biological Significance, and Opportunities for Redox Metabolomics and Personalized Medicine. Antioxid Redox Signal (2017) 0.79
Magnetic resonance imaging with gadoxetic acid for local tumour progression after radiofrequency ablation in patients with hepatocellular carcinoma. Eur Radiol (2016) 0.79
Ten challenges for systems medicine. Front Genet (2012) 0.79
Multi-study integration of brain cancer transcriptomes reveals organ-level molecular signatures. PLoS Comput Biol (2013) 0.79
Personalised medicine, disease prevention, and the inverse care law: more harm than benefit? Eur J Epidemiol (2014) 0.79
Molecular and genetic inflammation networks in major human diseases. Mol Biosyst (2016) 0.79
Metabolomics: Bridging the Gap between Pharmaceutical Development and Population Health. Metabolites (2016) 0.78
Jumping on the Train of Personalized Medicine: A Primer for Non- Geneticist Clinicians: Part 3. Clinical Applications in the Personalized Medicine Area. Curr Psychiatry Rev (2014) 0.78
An Altered Treatment Plan Based on Direct to Consumer (DTC) Genetic Testing: Personalized Medicine from the Patient/Pin-cushion Perspective. J Pers Med (2012) 0.78
Translating colorectal cancer prevention through the guanylyl cyclase C signaling axis. Expert Rev Clin Pharmacol (2013) 0.78
Bridging the Communication Divide: A Role for Health Psychology in the Genomic Era. Prof Psychol Res Pr (2012) 0.78
Recent advances in nanobiotechnology and high-throughput molecular techniques for systems biomedicine. Mol Cells (2013) 0.78
Mass Spectrometry-based Proteomics and Peptidomics for Systems Biology and Biomarker Discovery. Front Biol (Beijing) (2012) 0.77
Post-genomics nanotechnology is gaining momentum: nanoproteomics and applications in life sciences. OMICS (2014) 0.77
Identification and individualized prediction of clinical phenotypes in bipolar disorders using neurocognitive data, neuroimaging scans and machine learning. Neuroimage (2016) 0.77
Toward the use of precision medicine for the treatment of head and neck squamous cell carcinoma. Oncotarget (2016) 0.76
Jumping on the Train of Personalized Medicine: A Primer for Non-Geneticist Clinicians: Part 1. Fundamental Concepts in Molecular Genetics. Curr Psychiatry Rev (2014) 0.76
The genetics and neurobiology of ESSENCE: The third Birgit Olsson lecture. Nord J Psychiatry (2015) 0.76
A multilevel pan-cancer map links gene mutations to cancer hallmarks. Chin J Cancer (2015) 0.76
Does parents' socio-economic status matter in intentions of vaccinating against human papillomavirus for adolescent daughters? Afr Health Sci (2015) 0.76
Integrative network modeling approaches to personalized cancer medicine. Per Med (2015) 0.75
Omics approaches to individual variation: modeling networks and the virtual patient. Dialogues Clin Neurosci (2016) 0.75
Towards Evidence-based Precision Medicine: Extracting Population Information from Biomedical Text using Binary Classifiers and Syntactic Patterns. AMIA Jt Summits Transl Sci Proc (2016) 0.75
Crossing the Boundaries of Our Current Healthcare System by Integrating Ultra-Weak Photon Emissions with Metabolomics. Front Physiol (2016) 0.75
The new field of 'precision psychiatry'. BMC Med (2017) 0.75
Are Randomized Controlled Trials the (G)old Standard? From Clinical Intelligence to Prescriptive Analytics. J Med Internet Res (2016) 0.75
Label-free microcavity biosensors: steps towards personalized medicine. Sensors (Basel) (2012) 0.75
The fountain of age: a remarkable 3D shape that portrays health and functional differences among the European elderly. Int J Environ Res Public Health (2014) 0.75
Health research 2.0: The use in research of personal fitness or health data shared on social network raises both scientific and ethical concerns. EMBO Rep (2014) 0.75
Challenges of cardiac image analysis in large-scale population-based studies. Curr Cardiol Rep (2015) 0.75
Systems Chronotherapeutics. Pharmacol Rev (2017) 0.75
Data integration to prioritize drugs using genomics and curated data. BioData Min (2016) 0.75
DISCOVERY OF MOLECULARLY TARGETED THERAPIES. Pac Symp Biocomput (2016) 0.75
Transforming big data into computational models for personalized medicine and health care. Dialogues Clin Neurosci (2016) 0.75
Translating genetics beyond bench and bedside: A comparative perspective on health care infrastructures for 'familial' breast cancer. Appl Transl Genom (2016) 0.75
Toward Precision Healthcare: Context and Mathematical Challenges. Front Physiol (2017) 0.75
Memantine before Mastectomy Prevents Post-Surgery Pain: A Randomized, Blinded Clinical Trial in Surgical Patients. PLoS One (2016) 0.75
Making sense of health care delivery Where does the close to community health care worker fit in? - The case for congestive heart failure. Indian Heart J (2015) 0.75
Precision medicine and molecular imaging: new targeted approaches toward cancer therapeutic and diagnosis. Am J Nucl Med Mol Imaging (2016) 0.75
Facial surface morphology predicts variation in internal skeletal shape. Am J Orthod Dentofacial Orthop (2016) 0.75
Animal-Free Chemical Safety Assessment. Front Pharmacol (2016) 0.75
Towards a "4I" approach to personalized healthcare. Clin Transl Med (2012) 0.75
A Perspective on Implementing a Quantitative Systems Pharmacology Platform for Drug Discovery and the Advancement of Personalized Medicine. J Biomol Screen (2016) 0.75
Radiomics: the bridge between medical imaging and personalized medicine. Nat Rev Clin Oncol (2017) 0.75
Developing a framework for digital objects in the Big Data to Knowledge (BD2K) commons: Report from the Commons Framework Pilots workshop. J Biomed Inform (2017) 0.75
The RUDY study: using digital technologies to enable a research partnership. Eur J Hum Genet (2017) 0.75
Can learning health systems help organisations deliver personalised care? BMC Med (2017) 0.75
Gene expression profiling predicts clinical outcome of breast cancer. Nature (2002) 71.36
A gene-expression signature as a predictor of survival in breast cancer. N Engl J Med (2002) 58.15
Genetics of gene expression surveyed in maize, mouse and man. Nature (2003) 22.17
A network view of disease and compound screening. Nat Rev Drug Discov (2009) 2.90
Systematic analysis of challenge-driven improvements in molecular prognostic models for breast cancer. Sci Transl Med (2013) 2.34
Small interfering RNA screens reveal enhanced cisplatin cytotoxicity in tumor cells having both BRCA network and TP53 disruptions. Mol Cell Biol (2006) 1.97
Developing predictive molecular maps of human disease through community-based modeling. Nat Genet (2012) 1.88
Expression profiling predicts outcome in breast cancer. Breast Cancer Res (2002) 1.81
Enabling transparent and collaborative computational analysis of 12 tumor types within The Cancer Genome Atlas. Nat Genet (2013) 1.80
Systems biology: integrating technology, biology, and computation. Mech Ageing Dev (2003) 1.63
Cancer biomarkers--an invitation to the table. Science (2006) 1.53
Toxicogenomics and drug discovery: will new technologies help us produce better drugs? Nat Rev Drug Discov (2002) 1.49
Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev (2004) 1.44
Leveraging crowdsourcing to facilitate the discovery of new medicines. Sci Transl Med (2011) 1.26
Crowdsourcing genetic prediction of clinical utility in the Rheumatoid Arthritis Responder Challenge. Nat Genet (2013) 1.21
Improving breast cancer survival analysis through competition-based multidimensional modeling. PLoS Comput Biol (2013) 1.20
Opening up to precompetitive collaboration. Sci Transl Med (2010) 1.18
Systematic assessment of analytical methods for drug sensitivity prediction from cancer cell line data. Pac Symp Biocomput (2014) 1.17
PERSONALIZED HYPOTHESIS TESTS FOR DETECTING MEDICATION RESPONSE IN PARKINSON DISEASE PATIENTS USING iPHONE SENSOR DATA. Pac Symp Biocomput (2016) 1.09
How molecular profiling could revolutionize drug discovery. Nat Rev Drug Discov (2005) 1.01
The Stream algorithm: computationally efficient ridge-regression via Bayesian model averaging, and applications to pharmacogenomic prediction of cancer cell line sensitivity. Pac Symp Biocomput (2014) 0.95
Cancer. Potential of the synthetic lethality principle. Science (2013) 0.94
The Use of Smartphones for Health Research. Acad Med (2017) 0.84
Impact of bioinformatic procedures in the development and translation of high-throughput molecular classifiers in oncology. Clin Cancer Res (2013) 0.84
Something in common. Sci Transl Med (2010) 0.84
Gene regulatory networks and embryonic specification. Proc Natl Acad Sci U S A (2008) 0.76